TNFα induces matrix metalloproteinase-9 expression in monocytic cells through ACSL1/JNK/ERK/NF-kB signaling pathways.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
01 09 2023
Historique:
received: 21 01 2023
accepted: 28 08 2023
medline: 4 9 2023
pubmed: 2 9 2023
entrez: 1 9 2023
Statut: epublish

Résumé

Studies have established the association between increased plasma levels of matrix metalloproteinase (MMP)-9 and adipose tissue inflammation. Tumor necrosis factor α (TNFα) was elevated in obesity and is involved in the induction of MMP-9 in monocytic cells. However, the underlying molecular mechanism was incompletely understood. As per our recent report, TNFα mediates inflammatory responses through long-chain acyl-CoA synthetase 1 (ACSL1). Therefore, we further investigated the role of ACSL1 in TNFα-mediated MMP-9 secretion in monocytic cells. THP-1 cells and primary monocytes were used to study MMP-9 expression. mRNA and protein levels of MMP-9 were determined by qRT-PCR and ELISA, respectively. Signaling pathways were studied using Western blotting, inhibitors, and NF-kB/AP1 reporter cells. We found that THP-1 cells and primary human monocytes displayed increased MMP-9 mRNA expression and protein secretion after incubation with TNFα. ACSL1 inhibition using triacsin C significantly reduced the expression of MMP-9 in the THP-1 cells. However, the inhibition of β-oxidation and ceramide biosynthesis did not affect the TNFα-induced MMP-9 production. Using small interfering RNA-mediated ACSL1 knockdown, we further confirmed that TNFα-induced MMP-9 expression/secretion was significantly reduced in ACSL1-deficient cells. TNFα-mediated MMP-9 expression was also significantly reduced by the inhibition of ERK1/ERK2, JNK, and NF-kB. We further observed that TNFα induced phosphorylation of SAPK/JNK (p54/46), ERK1/2 (p44/42 MAPK), and NF-kB p65. ACSL1 inhibition reduced the TNFα-mediated phosphorylation of SAPK/JNK, c-Jun, ERK1/2, and NF-kB. In addition, increased NF-κB/AP-1 activity was inhibited in triacsin C treated cells. Altogether, our findings suggest that ACSL1/JNK/ERK/NF-kB axis plays an important role in the regulation of MMP-9 induced by TNFα in monocytic THP-1 cells.

Identifiants

pubmed: 37658104
doi: 10.1038/s41598-023-41514-6
pii: 10.1038/s41598-023-41514-6
pmc: PMC10474281
doi:

Substances chimiques

NF-kappa B 0
triacsin C 6M6D4602I5
Tumor Necrosis Factor-alpha 0
Matrix Metalloproteinase 9 EC 3.4.24.35
ACSL1 protein, human EC 6.2.1.3
Coenzyme A Ligases EC 6.2.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

14351

Informations de copyright

© 2023. Springer Nature Limited.

Références

Cell Physiol Biochem. 2014;34(3):929-42
pubmed: 25200491
Cell Physiol Biochem. 2019;52(3):397-407
pubmed: 30845379
Oncogene. 1997 Apr 24;14(16):1995-8
pubmed: 9150367
Diabetes Metab Res Rev. 2019 Feb;35(2):e3087
pubmed: 30339734
Cell. 1998 May 1;93(3):411-22
pubmed: 9590175
J Clin Endocrinol Metab. 2010 Jun;95(6):2993-3001
pubmed: 20392866
Cell Metab. 2010 Jul 7;12(1):53-64
pubmed: 20620995
Cell Physiol Biochem. 2016;39(3):889-900
pubmed: 27497609
Semin Immunol. 2014 Jun;26(3):253-66
pubmed: 24958609
Clin Exp Allergy. 2000 Jan;30(1):48-55
pubmed: 10606930
J Inflamm Res. 2022 Jul 27;15:4291-4302
pubmed: 35923906
Int J Retina Vitreous. 2022 Jun 21;8(1):44
pubmed: 35729613
FEBS Lett. 1998 Sep 11;435(1):29-34
pubmed: 9755853
Metabolism. 2015 Apr;64(4):527-38
pubmed: 25633268
Endothelium. 2008 Jul-Aug;15(4):219-24
pubmed: 18663625
Future Lipidol. 2008;3(5):545-556
pubmed: 18978945
J Cell Physiol. 2004 Mar;198(3):417-27
pubmed: 14755547
J Periodontal Res. 2012 Apr;47(2):236-42
pubmed: 22035412
J Immunol. 2018 May 15;200(10):3599-3611
pubmed: 29632147
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt B):180-185
pubmed: 26621196
J Cancer. 2016 Jan 01;7(1):42-9
pubmed: 26722359
Glia. 2002 Sep;39(3):279-91
pubmed: 12203394
Cell Physiol Biochem. 2019;52(4):908-921
pubmed: 30964608
Sci Rep. 2021 Apr 15;11(1):8259
pubmed: 33859296
Biol Reprod. 2010 Sep;83(3):481-7
pubmed: 20463356
Shock. 2001 Feb;15(2):135-42
pubmed: 11220642
J Biomed Sci. 2014 Feb 05;21:12
pubmed: 24502696
Cell Physiol Biochem. 2017;41(5):1993-2003
pubmed: 28419983
Arthritis Res. 2000;2(3):189-202
pubmed: 11094428
Biochem Biophys Res Commun. 2017 Jun 10;487(4):903-909
pubmed: 28465234
Sci Rep. 2020 Oct 1;10(1):16364
pubmed: 33004937
JCI Insight. 2020 Jun 4;5(11):
pubmed: 32369451
PLoS One. 2016 Oct 3;11(10):e0162667
pubmed: 27695085
J Immunol. 2000 Nov 15;165(10):5788-97
pubmed: 11067938
Mol Hum Reprod. 2006 Apr;12(4):225-32
pubmed: 16520344
J Mol Cell Cardiol. 2016 May;94:1-9
pubmed: 26995156
Biol Chem. 2006 Jan;387(1):69-78
pubmed: 16497166
J Biol Chem. 2013 Apr 5;288(14):9957-9970
pubmed: 23426369
Anticancer Res. 2014 Mar;34(3):1355-66
pubmed: 24596383
J Immunol. 2002 Aug 1;169(3):1401-9
pubmed: 12133965
Nat Rev Rheumatol. 2016 Jan;12(1):37-48
pubmed: 26633290
Oral Dis. 2017 Mar;23(2):199-209
pubmed: 27868311
Cells. 2022 Sep 15;11(18):
pubmed: 36139454
J Leukoc Biol. 2019 Oct;106(4):787-790
pubmed: 31269272
Atherosclerosis. 2005 Jan;178(1):207-15
pubmed: 15585220
J Neuroinflammation. 2012 Dec 13;9:268
pubmed: 23234315
Int J Mol Sci. 2021 Jul 19;22(14):
pubmed: 34299302
Int J Mol Sci. 2021 Sep 29;22(19):
pubmed: 34638857
Biomedicines. 2020 Oct 09;8(10):
pubmed: 33050324
Bratisl Lek Listy. 2005;106(3):127-32
pubmed: 16026148
Biomedicines. 2021 Oct 29;9(11):
pubmed: 34829801
Eur J Microbiol Immunol (Bp). 2011 Dec;1(4):302-10
pubmed: 24516737

Auteurs

Areej Al-Roub (A)

Immunology and Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.

Nadeem Akhter (N)

Immunology and Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.

Fatema Al-Rashed (F)

Immunology and Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.

Ajit Wilson (A)

Immunology and Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.

Fawaz Alzaid (F)

Bioenergetic Department, Dasman Diabetes Institute, 15462, Dasman, Kuwait.
Enfants Malades (INEM), INSERM U1151/CNRS UMRS8253, IMMEDIAB, Université de Paris Cité, 75015, Paris, France.

Fahd Al-Mulla (F)

Genetics and Bioinformatics, Dasman Diabetes Institute, 15462, Dasman, Kuwait.

Sardar Sindhu (S)

Immunology and Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait.
Animal and Imaging Core Facility, Dasman Diabetes Institute, 15462, Dasman, Kuwait.

Rasheed Ahmad (R)

Immunology and Microbiology Department, Dasman Diabetes Institute, Kuwait City, Kuwait. rasheed.ahmad@dasmaninstitute.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH